These novel therapies , Semaglutide , represent a remarkable advancement in addressing type 2 diabetes and conceivably other conditions . They all are classified as GLP-1 pathway activators , signifying these substances to replicate the natural GLP-1 substance , enhancing insulin release and suppressing food intake. Despite Tirzepatide each one … Read More